These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21238824)

  • 1. Update on morphea: part II. Outcome measures and treatment.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):231-42; quiz 243-4. PubMed ID: 21238824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphea: Current concepts.
    Florez-Pollack S; Kunzler E; Jacobe HT
    Clin Dermatol; 2018; 36(4):475-486. PubMed ID: 30047431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
    Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
    Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of morphea treatments and therapeutic algorithm.
    Zwischenberger BA; Jacobe HT
    J Am Acad Dermatol; 2011 Nov; 65(5):925-41. PubMed ID: 21645943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study about evaluation of efficacy of methotrexate in localized scleroderma using ultrasonography.
    Zhang F; Li J; Zhao Q; Liu H; Zhang F
    Skin Res Technol; 2023 Mar; 29(3):e13300. PubMed ID: 36973989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
    Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
    Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphea and localized scleroderma in children.
    Vierra E; Cunningham BB
    Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case of Bullous Morphea Resistant to Methotrexate and Phototherapy Successfully Treated With Mycophenolate Mofetil.
    Cuellar-Barboza A; Alberto Cardenas-De La Garza J; Daniel Villarreal-Villarreal C; Ocampo-Candiani J; Gomez-Flores M; Welsh O; Herz-Ruelas ME
    J Drugs Dermatol; 2018 Oct; 17(10):1123-1125. PubMed ID: 30365594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized scleroderma.
    Kreuter A
    Dermatol Ther; 2012; 25(2):135-47. PubMed ID: 22741933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypopigmented micropapules in apparently quiescent morphea lesions: a manifestation of disease activity.
    García-Romero MT; Taylor G; Laxer R; Pope E
    Dermatol Online J; 2013 Aug; 19(8):19268. PubMed ID: 24021446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localized scleroderma (morphea)].
    Bono W; Dupin N
    Presse Med; 2006 Dec; 35(12 Pt 2):1923-8. PubMed ID: 17159718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach.
    Marrani E; Foeldvari I; Lopez JA; Cimaz R; Simonini G
    Semin Arthritis Rheum; 2018 Dec; 48(3):495-503. PubMed ID: 29655520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel multispectral imaging to predict disease progression in pediatric morphea.
    O'Connor C; McCarthy S; Kiely L; McAuliffe MAP; Bennett M
    Pediatr Dermatol; 2024; 41(2):229-233. PubMed ID: 38305508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the Systemic Treatment of Pediatric Localized Scleroderma.
    Foeldvari I
    Paediatr Drugs; 2019 Dec; 21(6):461-467. PubMed ID: 31667717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study.
    Kroft EB; Groeneveld TJ; Seyger MM; de Jong EM
    Am J Clin Dermatol; 2009; 10(3):181-7. PubMed ID: 19354332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history.
    Kaushik A; Mahajan R; De D; Handa S
    Clin Exp Dermatol; 2020 Aug; 45(6):679-684. PubMed ID: 32449205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphea and other localized forms of scleroderma.
    Vasquez R; Sendejo C; Jacobe H
    Curr Opin Rheumatol; 2012 Nov; 24(6):685-93. PubMed ID: 23018858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.